Sensitivity to radiation and cycle-active drugs as a function of stem cell compartment repletion.
We have studied the sensitivity of normal mouse hemopoietic tissue to radiation and cycle-active drugs in relation to stem cell compartment repletion. Recovery of erythropoiesis in endogenous spleen colonies, blood reticulocytes, and 30-day survivals were determined in mice after an initial large dose of partial-body irradiation. We found that the normal stem cell compartment is more sensitive to cycle-independent modes of therapy, like radiation and cyclophosphamide, than it is to cycle-active agents like cytosine arabinoside and methotrexate. The depleted stem cell compartment exhibits marked sensitivity to cycle-independent agents but less to cycle-active agents, which, however, suppress its recovery more than they do the normal. The overshoot phase of recovery is relatively resistant to either cycle-independent or cycle-active agents. A reticulocytosis following a reticulocytopenia signals the overshoot phase of stem cell compartment recovery and relatively increased resistance. These findings may prove useful in designing chemotherapy regimens and in anticipating marrow recovery in planning for supportive care in patients with neoplastic disease.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004906:Erythrocyte Count; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000528:radiation effects*; D007501:Iron / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D011829:Radiation Dosage; D011830:Radiation Effects; D012156:Reticulocytes; D013154:Spleen / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D014965:X-Rays
D000970:Antineoplastic Agents; D003561:Cytarabine; D003520:Cyclophosphamide; D007501:Iron; D008727:Methotrexate